ATS has appointed Inés Serrano as its new head of development as part of a push into original formats and co-productions. “If it’s a big, ambitious reality format with international scale, it starts ...

– Rademikibart significantly improved airway function, as measured by FEV1, within a day and significantly reduced acute exacerbations in patients with inflammation-mediated chronic asthma strongly ...

Connect Biopharma to present data on rademikibart for asthma and COPD at ATS 2025, initiating Phase 2 trials in 2025. Connect Biopharma Holdings Limited announced its plans to present four posters at ...

aTyr Pharma, Inc. announced it will present three posters at the American Thoracic Society (ATS) 2025 International Conference in San Francisco, showcasing its lead candidate efzofitimod, currently ...

CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today released its FY2023 Sustainability Report for the period ending March 31, 2023. This is the ...